The setting
's gives people exercise and rehabilitation programs for pain in muscles and joints. They use an app and motion-sensing devices from anywhere, and a physical therapist directs the treatment plan.
The renewal needs a guarantee that buyers can verify without promising more than the evidence supports.
The employer wants financial accountability, while clinical review protects the boundary between measured outcomes and claims savings.
Who you’d be doing this for
“Finance asked why enrollment is still low when MSK spend keeps showing up in our forecast.”
Kyungho Yoon · Benefits Manager · a character in this brief
Owns the employer's covered health-benefit portfolio and must justify renewal to finance and procurement.
What is at stake
A major employer will tie at least 25% of its MSK fees to performance or open the benefit to competing vendors. You must weigh an enrollment promise buyers can verify against a claims-savings promise that carries more commercial upside.
Why it isn’t already fixed
Every obvious fix costs something else. That’s the part you’d have to decide.
- commercial upside vs. evidence discipline
- enrollment visibility vs. claims accountability
- contract simplicity vs. buyer-specific proof
- renewal speed vs. clinical review
Why Sword Health
Thrive's clinician-supervised care model must remain credible when employers demand performance-linked fees for MSK benefits.
Written with these in mind
Not your kind of problem? 42 more at Sword Health, or browse every organization.
Where the organization context comes fromThe postings this brief was written from, and the reporting read before it.
The organization context comes from public information. The situation and characters are written for the brief.
Job postings it was written from
Public descriptions of the work at Sword Health. They are listed as sources, not as openings. The lines under a posting are its own words, where it meets this brief.
- Head of Go-to-Market, Thrive (opens in a new tab)
- The role sits at the intersection of product marketing, competitive intelligence, and commercial enablement, and it is one of the three leadership roles on the Thrive team alongside the Head of Product and the Head of Clinical, reporting to the General Manager.
- MSK is a category where several offerings look similar on a benefits consultant's comparison grid and are not remotely similar in practice, and the work is to make the difference obvious, evidenced, and tangible — in the materials, in the buyer's language, and in the room where the decision gets made.
- Senior Marketing Operations Specialist (opens in a new tab)
- Work cross-functionally with various teams, including Enrollment, Growth, Member Engagement, Content, Creative, Data, Product & Engineering to launch communications across Sword-owned channels
- Ensure that Marketing Operations standards are met, including proper naming conventions, event conversion tagging, and QA prior to campaign deployment
- Performance Marketing Manager (opens in a new tab)
- You own our paid channels, with Meta first and Google next, and you are accountable for one thing above all: bringing in more qualified leads at a lower cost.
- Paid media management: Plan, run and optimise campaigns on Meta, then expand to Google Search and other channels as we grow our mix
- Marketing Manager · no longer posted
- This role sits at the center of a cross-functional group of designers, clinicians, copywriters, and marketing operations partners, and is responsible for turning a deep understanding of member needs into content that drives engagement and enrollment.
- Analyze the main performance metrics of each channel (e.g., open and click rates, enrollment conversion, CPA, and engagement) and turn the findings into clear recommendations
- Head of Go-to-Market, AI Care Operations (opens in a new tab)
- The role sits at the intersection of product marketing, competitive intelligence and commercial enablement.
- The category story: why AI care management that does the work beats both headcount and AI tools that only assist the people doing it
Reporting read before this brief was written
The pieces closest to the situation in this brief.
BGH's August 2026 survey finds most employers had already locked in their 2026 benefits budgets before this cost data emerged, meaning many cannot make major cost-cutting changes until 2028 at the earliest.
Employers at an ‘inflection point’ as health costs near double-digit increases | HR Dive (opens in a new tab) · hrdive.com · Aug 27, 2026
As of August 2026, 95% of employers surveyed by BGH have issued an RFP for at least one vendor category, with 58% planning to replace underperforming vendors and 83% increasing the scope of performance guarantees demanded from health benefit partners.
Employers face ‘existential reckoning’ as health costs surge | Healthcare Dive (opens in a new tab) · healthcaredive.com · Aug 26, 2026
PHTI's September 2026 State of Digital Health Purchasing survey of 321 decision-makers finds 68% of employers and 55% of health plans now use performance-based contracts for digital health tools, with 85% of those contracts tying at least a quarter of fees to performance.
PHTI Survey Finds Majority of Employers and Health Plans Are Using Performance-Based Contracting to Pay for Digital Health Tools (opens in a new tab) · phti.org · Sep 29, 2026
This is the setup. The work is inside.
Running it puts you in the room: the full situation and its constraints, stakeholders who push back in their own words, and the decisions that are yours to make. What you produce becomes a Day One Plan — work you can show someone instead of describing.
Where similar work appears
Other live briefs connected to this one, and what connects them.
Similar problems at other organizations
Like this one, each of these turns on committing to a deal before it checks out.
A 48,000-life renewal is stalled because finance does not accept the current savings claim.
You must weigh a defensible guarantee against preserving broad member access.
A CFO is challenging rising fertility claims while enrollment remains below the prior commitment.
You must weigh treatment continuity against a guarantee finance will accept and the business can support.
A 45,000-life employer deal is stalled over an outcomes measure the committee can independently verify.
You must weigh a stronger guarantee against terms Finance can support and Legal can defend.
The same setting, from another role
Each is set around Sword Health’s Virtual musculoskeletal (MSK) care, written for a different role. They’re separate briefs, not the same scenario.
Five of seven incoming benefits owners couldn't explain where member access questions belong.
You must weigh a focused handover against a broader service that prepares them to defend the benefit at annual planning.
CSMs find unfinished launch steps even when health-plan accounts appear on track.
You decide whether AI can flag a stalled commitment from correspondence or must wait for a CSM to confirm which date applies.
Employers are asking to hold back part of MSK fees when enrollment or outcomes fall short.
You have to weigh a compelling commercial commitment against measures that clinical, legal, and buyers can defend.
Other problems with a similar purpose
In each of these, as in this one, the aim is to turn a tangle of ecosystem partners into a buying decision a customer can confidently say yes to.
Buyers want AI-agent workflows, but partners cannot yet offer a repeatable path from messy knowledge to a build-ready project.
You have to weigh partner reach against the qualification standard sellers need.
Buyers are rebuilding approved product decisions after every handoff, and bundled suites are becoming the default alternative.
You must weigh a focused partner offer against the proof, approvals, and buyer commitments needed to make it repeatable.
Qualified enterprise opportunities are stalling when buyers cannot connect Marketplace purchasing to rollout support.
You must weigh a fast, focused partner motion against the coverage needed across complex enterprise accounts.
